Bionoia Where life meets thought ⌕
Back to Journal
Journal › Mitochondrial biology
Discovery

Impact of aldehyde dehydrogenase 2 deficiency on tissue-specific mitochondrial metabolism in aging mice

Speculation
Read original paper
Editor's note
Toxic aldehyde buildup in mitochondria may drive tissue aging differently across organs—a finding that could explain why some tissues decline faster than others and why people carrying a common ALDH2 mutation face accelerated aging in specific organs like the heart and brain. This incremental mechanistic study in mice maps where aldehyde metabolism fails during aging and warrants follow-up in human tissues. Cardiologists, neurologists, and gerontologists studying organ-specific vulnerability should take note.

Source: openalex · Origin: FR · Márcio A. C. Ribeiro, Vanessa Morais Lima, Thiago N. Menezes, Wenjin Yang, Juliane C. Campos · bioRxiv (Cold Spring Harbor Laboratory) · 2026-05-26

URL: https://doi.org/10.64898/2026.05.25.727652

AI rationale (4/5, tier: preliminary): Directly addresses mitochondrial bioenergetics & aldehyde metabolism in aging; animal model limits tier despite mechanistic relevance.

Age-related diseases arise from prolonged exposure to genetic and/or environmental factors, ultimately leading to cumulative and irreversible degeneration of tissues and the organism as a whole. We previously reported that accumulation of mitochondrially-generated aldehydes (i.e., 4-hydroxynonenal and acetaldehyde) causes mitochondrial dysfunction and accelerates the progression of age-related diseases. However, the contribution of mitochondrial aldehyde metabolism to aging (via aldehyde dehydrogenase 2, ALDH2) remains elusive. Here, we provide a comprehensive analysis of aldehyde metabolism and mitochondrial bioenergetics across different tissues in aging mice. We also address how mitochondrial function is influenced by the highly prevalent human inactivating ALDH2 E504K point mutation (ALDH2E504K) during aging. The liver metabolism was relatively resilient to aging, showing enhanced ALDH2 activity and improved mitochondrial coupling. Strikingly, aging-associated liver resilience was lost in ALDH2E504K mice. Aged hearts exhibited mixed outcomes including impaired mitochondrial basal respiration, improved ADP-driven respiration, and decreased ALDH2 detox capacity. The ALDH2E504K mutation exacerbated the already impaired cardiac ALDH2 detox capacity in aging. Strikingly, aging brain displayed pronounced vulnerability, with decreased ALDH2 activity, impaired mitochondrial bioenergetics and defective ALDH2 detox capacity. These changes were paralleled by impaired cognitive and behavioral functions in aged mice. As proof of concept, either the presence of ALDH2E504K mutation or acute ethanol challenge worsened cognitive and behavioral dysfunction in aging mice. Finally, we assessed in vitro efficacy of pharmacological ALDH2 activation in aging tissues. Collectively, these findings unravel the contribution of ALDH2E504K mutation to mitochondrial metabolism during aging; highlighting the detrimental synergy between genetic ALDH2 deficiency and aging in brain metabolism and physiology.

Related articles in this corpus

Parallel
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence
Both studies investigate mitochondrial dysfunction as a driver of aging and age-related pathology, but approach the problem through different mechanisms: Article A focuses on mtRNA release and inflammation/senescence while Article B examines aldehyde accumulation and metabolic dysfunction.
Parallel
Heterogeneous Mitochondrial Gene Expression in SH-SY5Y Cells Following ERRa and ERRy Depletion Reveals Divergent Stress Responses
Both articles investigate mitochondrial dysfunction and its molecular consequences in cellular aging/stress, but approach it from different angles—Article A focuses on aldehyde accumulation and ALDH2 deficiency while Article B examines ERRα/γ-mediated transcriptional stress responses in neuronal cells.
Parallel
NMN/NAD+ enhances SIRT2-modulated microtubule dynamics to improve mitochondrial and mitophagy functions in senescent cells
Both articles investigate mitochondrial dysfunction and aging through different molecular mechanisms—Article A via aldehyde metabolism and ALDH2, Article B via NAD+/SIRT2 signaling—but converge on mitochondrial function as a central target for preventing age-related disease.
Parallel
Mito_Plot: open-source pipeline for quantification and visualization of mitochondrial DNA heteroplasmy
Both articles address mitochondrial dysfunction and its role in aging and disease, but Article A focuses on detection/visualization methodology for mtDNA variants while Article B investigates a specific molecular mechanism (aldehyde metabolism) underlying age-related mitochondrial pathology.
Parallel
SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma
Both articles investigate mitochondrial metabolic dysfunction as a disease mechanism, but Article A focuses on aldehyde detoxification in aging while Article B examines cardiolipin synthesis regulation in cancer, with no direct mechanistic overlap.
Published 2026-05-28 · Last kit-update 2026-05-28